328 related articles for article (PubMed ID: 25400441)
1. Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer.
Wang XY; Yang F; Jin C; Fu DL
World J Gastroenterol; 2014 Nov; 20(42):15580-9. PubMed ID: 25400441
[TBL] [Abstract][Full Text] [Related]
2. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
[TBL] [Abstract][Full Text] [Related]
3. The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.
Kim MJ; Lee KH; Lee KT; Lee JK; Ku BH; Oh CR; Heo JS; Choi SH; Choi DW
Pancreas; 2012 Aug; 41(6):897-903. PubMed ID: 22699202
[TBL] [Abstract][Full Text] [Related]
4. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
5. The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients.
Jung W; Jang JY; Kang MJ; Chang YR; Shin YC; Chang J; Kim SW
HPB (Oxford); 2016 Jan; 18(1):57-64. PubMed ID: 26776852
[TBL] [Abstract][Full Text] [Related]
6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
7. The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma.
Wang XY; Yang F; Jin C; Guan YH; Zhang HW; Fu DL
Hepatogastroenterology; 2014 Oct; 61(135):2102-9. PubMed ID: 25722999
[TBL] [Abstract][Full Text] [Related]
8. Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.
Buchs NC; Bühler L; Bucher P; Willi JP; Frossard JL; Roth AD; Addeo P; Rosset A; Terraz S; Becker CD; Ratib O; Morel P
J Gastroenterol Hepatol; 2011 Apr; 26(4):657-62. PubMed ID: 21155879
[TBL] [Abstract][Full Text] [Related]
9. Staging of pancreatic adenocarcinoma by imaging studies.
Wong JC; Lu DS
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1301-8. PubMed ID: 18948228
[TBL] [Abstract][Full Text] [Related]
10. [Benefit of PET/CT in the preoperative staging in pancreatic carcinomas].
Kysucan J; Lovecek M; Klos D; Tozzi I; Koranda P; Buriánková E; Neoral C; Havlík R
Rozhl Chir; 2010 Aug; 89(7):433-40. PubMed ID: 20925260
[TBL] [Abstract][Full Text] [Related]
11. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
12. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.
Strobel K; Heinrich S; Bhure U; Soyka J; Veit-Haibach P; Pestalozzi BC; Clavien PA; Hany TF
J Nucl Med; 2008 Sep; 49(9):1408-13. PubMed ID: 18703604
[TBL] [Abstract][Full Text] [Related]
14. Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?
Pappas SG; Christians KK; Tolat PP; Mautz AP; Lal A; McElroy L; Gamblin TC; Turaga KK; Tsai S; Erickson B; Ritch P; Evans DB
HPB (Oxford); 2014 Jan; 16(1):70-4. PubMed ID: 23496023
[TBL] [Abstract][Full Text] [Related]
15. PET/CT of cancer patients: part 1, pancreatic neoplasms.
Dibble EH; Karantanis D; Mercier G; Peller PJ; Kachnic LA; Subramaniam RM
AJR Am J Roentgenol; 2012 Nov; 199(5):952-67. PubMed ID: 23096166
[TBL] [Abstract][Full Text] [Related]
16. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
17. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
18. The Role of Positron Emission Tomography/Computed Tomography in Management and Prediction of Survival in Pancreatic Cancer.
Nunna P; Sheikhbahaei S; Ahn S; Young B; Subramaniam RM
J Comput Assist Tomogr; 2016; 40(1):142-51. PubMed ID: 26484961
[TBL] [Abstract][Full Text] [Related]
19. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
20. Prognostication and response assessment in liver and pancreatic tumors: The new imaging.
De Robertis R; Tinazzi Martini P; Demozzi E; Puntel G; Ortolani S; Cingarlini S; Ruzzenente A; Guglielmi A; Tortora G; Bassi C; Pederzoli P; D'Onofrio M
World J Gastroenterol; 2015 Jun; 21(22):6794-808. PubMed ID: 26078555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
